RNA, U6 small nuclear 81, pseudogene (RNU6-81P)

RNU6-81P refers to a **pseudogene** copy of the U6 small nuclear RNA (snRNA) locus, specifically the 81st annotated pseudogenic variant in human genome databases. Pseudogenes do not produce functional RNA; instead, they are characterized as non-functional DNA sequences derived from ancestral, functional genes. The canonical, functional U6 snRNA gene encodes a highly conserved component of the spliceosome—a molecular machine responsible for the removal of introns from pre-mRNA in eukaryotic cells[1][2]. U6 snRNA plays a catalytic role in mRNA splicing as part of the U6 snRNP, undergoing extensive post-transcriptional modifications and structural changes during spliceosome assembly and activation[1][2]. However, **pseudogenes such as RNU6-81P no longer encode functional snRNA and do not participate in spliceosomal activity**. Rather, they are genomic sequences resulting from retrotransposition or gene duplication events[3][4]. Although U6 snRNA pseudogenes are common in vertebrate genomes, and their abundance may reflect evolutionary dynamics related to retrotransposons, these loci are not recognized as biological or therapeutic targets. For gene-centric databases, the RNU6-81P locus does not have direct links to protein function, disease association, or drug interaction, nor is it used as a biomarker[4]. Key points: - RNU6-81P is a **pseudogene** (not a protein, enzyme, receptor, transport molecule, or transcription factor)[4]. - It is **not a therapeutic target**, and is considered **non-functional/non-coding**[4]. - There are **no known biological functions, disease associations, or drug interactions** attributed specifically to RNU6-81P[4]. - Its naming follows the convention for U6 snRNA-derived pseudogenes, of which there are many in the human genome[2][3]. - The functional relevance of U6 snRNA pseudogenes is currently thought to be negligible. If you are seeking a functional molecule/receptor, the canonical entity is simply **U6 small nuclear RNA** (U6 snRNA), not RNU6-81P. The latter is an inactive pseudogene and not suitable for therapeutic targeting, biomarker use, or mechanism-of-action analysis.

Other names

RNU6-81RNU6-81P